ClinicalTrials.Veeva

Menu

Exercise Intolerance in Elderly Patients With HFpEF(Heart Failure With Preserved Ejection Fraction) (SECRET-II)

Wake Forest University (WFU) logo

Wake Forest University (WFU)

Status

Completed

Conditions

Heart Failure, Diastolic
Obesity

Treatments

Behavioral: dietary, and aerobic exercise
Behavioral: dietary, aerobic and resistance training

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT02636439
R01AG018915 (U.S. NIH Grant/Contract)
IRB00032364

Details and patient eligibility

About

The purpose of this study is to examine the effects of weight loss via hypocaloric diet (CR)and aerobic exercise (AT) compared to the effects of weight loss via hypocaloric diet (CR), aerobic training (AT)and resistance training (RT).

Full description

Heart failure with preserved ejection fraction (HFPEF) is the most common form of HF, is nearly unique to the older population, particularly older women, and is increasing in prevalence. Exercise intolerance, with severe exertional dyspnea and fatigue, is the primary manifestation of chronic HFPEF and is a major determinant of these patients' severely reduced quality of life (QOL). However, its pathophysiology is poorly understood and its optimal treatment remains undefined.

Our recent data and others' indicate that in older HFPEF patients, both increased adiposity and abnormalities in skeletal muscle are major contributors to exercise intolerance and potential therapeutic targets. Obesity is one of the strongest risk factors for HFPEF, and is a robust predictor of physical disability in older persons. The investigator recently reported that in HFPEF compared to age-matched controls, percent total and leg lean mass are significantly reduced and independently predict exercise capacity.

Using MRI and needle biopsy of the thigh muscle, the investigators found increased fat infiltration, reduced capillary density and percent type I oxidative fibers, and trends for reduced muscle mitochondrial mass and function. Reduced exercise capacity was related to each of these muscle abnormalities, supporting their important role in HFPEF.

Diet, with or without aerobic exercise, can increase exercise capacity and quality of life in older obese persons with a variety of disorders, but usually results in significant loss of skeletal muscle mass, which could potentially have adverse long term consequences. The purpose of this trial is to determine if addition of resistance training to diet plus aerobic exercise training can improve skeletal muscle mass and function in HFPEF.

Multiple lines of evidence and our preliminary data indicate that resistance training (RT) may be an ideal addition to CR+AT for HFPEF, since RT reliably increases muscle mass, quality, strength, and function, significantly more than AT, and can prevent nearly 50% of the muscle mass loss during CR.

Therefore, the primary aim of the proposed study is to conduct a randomized, single-blinded 20-week intervention trial of RT added to CR+AT in 84 overweight / obese (BMI greater than 28 kg/m2), older (age greater than 60 years) HFPEF patients to test the following primary hypothesis:

The addition of resistance training to CR+AT will improve exercise capacity.

Enrollment

88 patients

Sex

All

Ages

60+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 60 years or older
  2. Ejection fraction ≥ 50%
  3. Left Ventricular Diastolic Dysfunction ≥ grade 1
  4. BMI ≥ 28 kg/m2
  5. HF symptoms/ signs by cardiologist review, using NHANES HF Clinical Score >/= 3 or Rich et al. criteria for HF

Exclusion criteria

  1. Valvular heart disease as the primary etiology of CHF (congestive heart failure)
  2. Significant change in cardiac medication or Heart Failure symptoms <6 weeks
  3. Hospitalization or urgent care visit <6 weeks
  4. Uncontrolled hypertension
  5. Uncontrolled diabetes
  6. Evidence of significant Chronic Obstructive Pulmonary Disease (COPD)
  7. Recent or debilitating stroke
  8. Cancer or other noncardiovascular conditions with life expectancy less than 2 years
  9. Significant anemia (<10 g/dL Hgb)
  10. Significant renal insufficiency (eGFR <30 mL/min/1.73m2)
  11. Pregnant or of child-bearing potential
  12. Psychiatric disease- uncontrolled major psychoses, depressions, dementia, or personality disorder
  13. Plans to leave area within the study period
  14. Refuses informed consent -

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

88 participants in 2 patient groups

dietary, and aerobic exercise
Active Comparator group
Description:
Intervention for diet-A hypocaloric diet will be developed to achieve a 2800 kcal/week deficit, which should produce about 0.4 kg (1 lb.) weight loss per week. Intervention for aerobic exercise-Based on initial evaluations and the stress testing results, (HR, VO2, RPE) an individual exercise prescription will be developed for aerobic training.
Treatment:
Behavioral: dietary, and aerobic exercise
dietary, aerobic and resistance training
Active Comparator group
Description:
Intervention for diet-A hypocaloric diet will be developed to achieve a 2800 kcal/week deficit, which should produce about 0.4 kg (1 lb.) weight loss per week. Intervention for aerobic exercise-Based on initial evaluations and the stress testing results, (HR, VO2, RPE) an individual exercise prescription will be developed for aerobic training. Intervention for resistance training- Additional weight resistant exercise will be added to this arm.
Treatment:
Behavioral: dietary, and aerobic exercise
Behavioral: dietary, aerobic and resistance training

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems